HomeAI · summaries
Storia in 5 fonti
Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts
Growing collaboration between multinational drug makers and Chinese companies not expected to slow after US move.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
theprint.in
Chinese pharma contractor under watch: Pentagon names WuXi AppTec on military list
The designation could threaten a key revenue stream for the drug contractor and complicate research, manufacturing and supply chains for American pharmaceutical firms.
- ·
fiercepharma.com
WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
After dodging a layer of U.S. scrutiny thus far, Chinese CDMO WuXi AppTec is back in the government’s crosshairs. The company is now listed in the U.S. | Inclusion on the…
